A company was facing significant challenges in a global clinical trial program with 30 studies for an uncommon indication. Not only did they need to transition all ongoing clinical trials to the Clario Clinical Adjudication platform for better analysis — but they also needed to do it within 60 days.
Download our case study to learn:
Download our case study to learn more about how ensure success for a clinical event adjudication process transition.